Gherardi, Romain K, Cadusseau, Josette, Authier, François-jérôme · Bulletin de l'Academie nationale de medecine · 2014
This review examines how aluminum-based vaccine adjuvants (immune-boosting ingredients) may rarely cause long-term health problems in susceptible people, including muscle pain, exhaustion, and brain fog that can last years. The researchers found that aluminum particles can travel from the injection site through the body to distant organs and the brain, and that a specific immune protein called MCP-1 may control how much this happens. For most people, aluminum adjuvants are safe, but genetic and environmental differences may make some individuals more vulnerable to prolonged effects.
This study provides a mechanistic framework for understanding how vaccine adjuvants might trigger post-immunization syndromes with symptoms overlapping ME/CFS, particularly cognitive dysfunction and exhaustion. Identifying MCP-1 as a putative biomarker of susceptibility could help stratify patients and guide future prevention or early intervention strategies for adjuvant-induced complications.
This study does not prove that alum adjuvants are a primary cause of ME/CFS in the general population, nor does it establish that vaccination is unsafe for most people. The work is mechanistic and animal-model based; it cannot definitively demonstrate human alum translocation or prove that MCP-1 elevation is causal rather than correlational. It also does not address whether MMF symptoms are sufficient to explain the full spectrum of ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Gherardi, Romain K, Cadusseau, Josette, & Authier, François-jérôme (2014). [Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].. Bulletin de l'Academie nationale de medecine. https://pubmed.ncbi.nlm.nih.gov/26259285/
BibTeX
@article{mecfsatlas-gherardi-2014-biopersistence-systemic,
author = {Gherardi, Romain K and Cadusseau, Josette and Authier, François-jérôme},
title = {[Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].},
journal = {Bulletin de l'Academie nationale de medecine},
year = {2014},
note = {PubMed: 26259285},
url = {https://www.mecfsatlas.com/evidence/gherardi-2014-biopersistence-systemic},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/gherardi-2014-biopersistence-systemic
Contribute
Private, reviewed by a human. Not a public comment thread.